Cargando…
1237. Inpatients with a beta-lactam antibiotic allergy label (BAAL) and unrevealed tolerance: A prevalence study aimed to prioritize non-invasive delabeling for antimicrobial stewardship programs
BACKGROUND: This study aimed to use data analytics to retrospectively identify the prevalence of inpatients across a system of hospitals with a BAAL who received and tolerated the culprit or related beta-lactam (BL) without proper documentation in the allergy profile of the electronic medical record...
Autores principales: | Dickens, Michael, Wang, Sheila K, Weslander, Erin, Qin, Mingyu, Tran, Hoang, Khankan, Nour, Sutton, Sarah, Peters, Anju T, Watts, Melissa M, Postelnick, Mike |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679250/ http://dx.doi.org/10.1093/ofid/ofad500.1077 |
Ejemplares similares
-
1221. Non-severe, non-immune mediated intolerances: simple targets for direct non-invasive delabeling opportunities of beta-lactam antibiotic allergy labels (BAAL)
por: Polisetty, Radhika S, et al.
Publicado: (2023) -
Approach for delabeling beta-lactam allergy in children
por: Sáenz de Santa María, R., et al.
Publicado: (2023) -
Baal
por: Brecht, Bertolt, 1898-1956
Publicado: (1970) -
Baal Babylone /
por: Arrabal, Fernando
Publicado: (1969) -
β‐Lactam allergy testing and delabeling—Experiences and lessons from Singapore
por: Heng, Yee Kiat, et al.
Publicado: (2020)